Analysts Notes: New Reports Compare Medical Affairs Teams for Major Psoriasis Treatments in US and EU5

When it comes to the services doctors need most, does your medical affairs team deliver? How do you measure up to competitors? Where can you stand to improve?

Questions like these can be difficult for pharma companies to answer without time-consuming research or costly consultations with external agencies, but thanks to a series of unique reports available off-the-shelf from FirstView, medical affairs teams are gaining insight into what doctors really think.

Based on surveys of practicing dermatologists, the US and EU5 editions of FirstView Medical Affairs Reputations: Psoriasis 2018 compares medical affairs teams for some of the leading psoriasis treatments, including Cosentyx, Enbrel, Humira, Otezla, Remicade, Stelara, Taltz, Tremfya and biosimilars, Inflectra and Renflexis. The EU5 report also includes teams for biosimilars, including Benepali, Inflectra, Remsima and Renflexis.

Physician needs and priorities?

An at-a-glance view of the 'need-gap analysis' for each drug highlights the activities physicians value the most and where they are happy with the support they are getting, as well as the key areas where satisfaction could be improved. Activities are categorised into primary and secondary importance to further aid interpretation of the results.

How to interact – and how often?

Find out if US survey respondents differ from their EU5 counterparts when it comes to the level of support required from medical affairs professionals. Do physicians prefer a combination of medical meetings, education events and one-to-ones, or are they embracing digital channels?

The physicians' wish list?

For US and European respondents, you'll be able to find out what the most valued attributes are when it comes to the support they need from medical affairs teams. Speed, accuracy, information on competitive products, support with grant applications and several other attributes are tested.

Pitching each team against the rest        

A key feature of the Medical Affairs Reputations report format is the EdgeMap. This offers a visual representation of competitive performance of each medical affairs team against each other, broken down by specific attributes. See instantly who leads and who lags for the core medical affairs activities including speed of response, provision of suitable resources, proof of clinical value and thought leadership opportunities – as well as other key factors.

Full Survey Results Now Available

These insights, along with the full survey results are included in FirstView Medical Affairs Reputations: Psoriasis 2018 for the US and EU5 markets, available for immediate purchase and download in the FirstView reports store.

Or contact FirstView for more information by calling calling +1 212-220-0880 or +44(0)20.7665.9240

To read more Analyst Notes articles, click here.